The Truth About Oral Peptide Delivery in 2026
Recent oral peptide approvals demonstrate that oral delivery is clinically feasible, challenging historical assumptions, says Catalent Pharma Solutions’s Dr Karunakar Sukuru.…
TR
By Tom Reyes · Markets Editor
Oct 28 12:56 ETSource: BioPharm International
From the source
Read at biopharminternational.comThe Truth About Oral Peptide Delivery in 2026
Recent oral peptide approvals demonstrate that oral delivery is clinically feasible, challenging historical assumptions, says Catalent Pharma Solutions’s Dr Karunakar Sukuru. Patient-centric formulation design can improve convenience and support development of more accessible peptide therapies. Explore more through Dr Sukuru’s interview.
